PortfoliosLab logo
SWBI vs. GMRE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SWBI and GMRE is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

SWBI vs. GMRE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Smith & Wesson Brands, Inc. (SWBI) and Global Medical REIT Inc. (GMRE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

SWBI:

-0.96

GMRE:

-0.74

Sortino Ratio

SWBI:

-1.19

GMRE:

-0.98

Omega Ratio

SWBI:

0.81

GMRE:

0.87

Calmar Ratio

SWBI:

-0.53

GMRE:

-0.42

Martin Ratio

SWBI:

-1.36

GMRE:

-1.73

Ulcer Index

SWBI:

28.50%

GMRE:

13.38%

Daily Std Dev

SWBI:

40.70%

GMRE:

28.81%

Max Drawdown

SWBI:

-96.59%

GMRE:

-58.92%

Current Drawdown

SWBI:

-69.75%

GMRE:

-55.25%

Fundamentals

Market Cap

SWBI:

$413.63M

GMRE:

$843.18M

EPS

SWBI:

$0.65

GMRE:

$0.03

PE Ratio

SWBI:

14.46

GMRE:

206.67

PS Ratio

SWBI:

0.84

GMRE:

6.10

PB Ratio

SWBI:

1.14

GMRE:

0.93

Total Revenue (TTM)

SWBI:

$333.90M

GMRE:

$142.42M

Gross Profit (TTM)

SWBI:

$89.53M

GMRE:

$103.00M

EBITDA (TTM)

SWBI:

$25.33M

GMRE:

$75.70M

Returns By Period

In the year-to-date period, SWBI achieves a -5.73% return, which is significantly higher than GMRE's -17.70% return.


SWBI

YTD

-5.73%

1M

-2.08%

6M

-27.87%

1Y

-38.98%

3Y*

-8.82%

5Y*

6.43%

10Y*

-0.54%

GMRE

YTD

-17.70%

1M

-19.17%

6M

-24.99%

1Y

-23.39%

3Y*

-13.64%

5Y*

-3.92%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Smith & Wesson Brands, Inc.

Global Medical REIT Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

SWBI vs. GMRE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SWBI
The Risk-Adjusted Performance Rank of SWBI is 1010
Overall Rank
The Sharpe Ratio Rank of SWBI is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of SWBI is 1010
Sortino Ratio Rank
The Omega Ratio Rank of SWBI is 77
Omega Ratio Rank
The Calmar Ratio Rank of SWBI is 1818
Calmar Ratio Rank
The Martin Ratio Rank of SWBI is 1111
Martin Ratio Rank

GMRE
The Risk-Adjusted Performance Rank of GMRE is 1313
Overall Rank
The Sharpe Ratio Rank of GMRE is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of GMRE is 1313
Sortino Ratio Rank
The Omega Ratio Rank of GMRE is 1313
Omega Ratio Rank
The Calmar Ratio Rank of GMRE is 2525
Calmar Ratio Rank
The Martin Ratio Rank of GMRE is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SWBI vs. GMRE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Smith & Wesson Brands, Inc. (SWBI) and Global Medical REIT Inc. (GMRE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current SWBI Sharpe Ratio is -0.96, which is comparable to the GMRE Sharpe Ratio of -0.74. The chart below compares the historical Sharpe Ratios of SWBI and GMRE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

SWBI vs. GMRE - Dividend Comparison

SWBI's dividend yield for the trailing twelve months is around 5.53%, less than GMRE's 13.55% yield.


TTM202420232022202120202019201820172016
SWBI
Smith & Wesson Brands, Inc.
5.53%5.05%3.39%4.38%1.63%0.56%0.00%0.00%0.00%0.00%
GMRE
Global Medical REIT Inc.
13.55%10.88%7.57%8.86%4.62%6.13%6.05%9.00%9.76%4.48%

Drawdowns

SWBI vs. GMRE - Drawdown Comparison

The maximum SWBI drawdown since its inception was -96.59%, which is greater than GMRE's maximum drawdown of -58.92%. Use the drawdown chart below to compare losses from any high point for SWBI and GMRE.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

SWBI vs. GMRE - Volatility Comparison

The current volatility for Smith & Wesson Brands, Inc. (SWBI) is 6.89%, while Global Medical REIT Inc. (GMRE) has a volatility of 12.15%. This indicates that SWBI experiences smaller price fluctuations and is considered to be less risky than GMRE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

SWBI vs. GMRE - Financials Comparison

This section allows you to compare key financial metrics between Smith & Wesson Brands, Inc. and Global Medical REIT Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00MJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
115.89M
34.62M
(SWBI) Total Revenue
(GMRE) Total Revenue
Values in USD except per share items

SWBI vs. GMRE - Profitability Comparison

The chart below illustrates the profitability comparison between Smith & Wesson Brands, Inc. and Global Medical REIT Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%JulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
24.1%
78.0%
(SWBI) Gross Margin
(GMRE) Gross Margin
SWBI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Smith & Wesson Brands, Inc. reported a gross profit of 27.95M and revenue of 115.89M. Therefore, the gross margin over that period was 24.1%.

GMRE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Global Medical REIT Inc. reported a gross profit of 27.01M and revenue of 34.62M. Therefore, the gross margin over that period was 78.0%.

SWBI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Smith & Wesson Brands, Inc. reported an operating income of 4.13M and revenue of 115.89M, resulting in an operating margin of 3.6%.

GMRE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Global Medical REIT Inc. reported an operating income of 9.56M and revenue of 34.62M, resulting in an operating margin of 27.6%.

SWBI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Smith & Wesson Brands, Inc. reported a net income of 1.66M and revenue of 115.89M, resulting in a net margin of 1.4%.

GMRE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Global Medical REIT Inc. reported a net income of 2.10M and revenue of 34.62M, resulting in a net margin of 6.1%.